Archive for 2006/09


M. D. Anderson, BCM, Launch Research Effort Targeting Asthma And Allergic Diseases

A new research alliance focuses on a molecular master switch suspected of igniting the inflammatory immune response that drives asthma and other allergic diseases.The University of Texas M. D. Anderson Cancer Center and Baylor College of Medicine have launched the Texas Medical Center Asthma and Allergic Diseases Cooperative Research Center, funded by a $5. [click link for full article]
(more...)


Avian Flu Pandemic Could Cost World 2 Trillion Dollars

The economic devastation caused by a bird flu pandemic could cost the world up 2 trillion dollars and at least 1 trillion dollars, according to The World Bank.Jim Adams, Vice President, East Asia & Pacific's Avian Influenza Task Force, World Health Organization, said in Singapore that the economic threat is still real and remains substantial. [click link for full article]
(more...)


Highly Drug-resistant Tuberculosis, Worldwide Warning Given

New forms of highly drug-resistant tuberculosis are emerging and action must be taken soon before they become widespread globally, says an editorial in this week's BMJ.The authors say that urgent action is needed to implement effective tuberculosis control strategies, especially in countries where tuberculosis control practices have been inadequate. [click link for full article]
(more...)


National Increase In Cases Of Legionnaires’ Disease, UK

The Health Protection Agency is investigating an increase in the number of cases of Legionnaires' disease reported since the beginning of August 2006. Reports have been received from all regions in England and Wales and include both cases acquired in the UK and abroad. [click link for full article]
(more...)


Potential New Affordable Diagnostic Test For TB

A technique that identifies proteins* in the blood particular to tuberculosis (TB) could be used to develop a new diagnostic test for the disease, according to an Online/Article published September 14, 2006 by The Lancet.At present sputum smear microscopy is often the only available and affordable diagnostic test in most developing countries where TB is endemic, but at best it can detect 50-60% of positive cases. [click link for full article]
(more...)


Partnership Between NIAID And Sequella Yields Promising New TB Drug For Clinical Testing

The need for new drugs against tuberculosis (TB) has never been more urgent, as the global burden of the disease continues to grow, and the incidence of extensive drug-resistant (XDR) TB, a virtually untreatable disease, continues to rise. A key component in advancing new health care interventions for TB is the creation of productive partnerships between pharmaceutical companies and the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health. [click link for full article]
(more...)


Herbal Medicine Symposium To Be Hosted By Penn

The University of Pennsylvania School of Medicine, School of Nursing, and the Morris Arboretum are jointly sponsoring a symposium on September 19-20, 2006 entitled Herbal Medicine: Perception, Practice and Rational Use. The symposium will bring together world-renowned experts in the field of herbal medicine. [click link for full article]
(more...)


Businesses, Government, NGOs Launch Alliance To Address HIV, TB In China

The Global Health Initiative of the World Economic Forum on Monday launched a public-private partnership that aims to address tuberculosis and HIV/AIDS in China, China Daily reports. [click link for full article]
(more...)


Is DOTS Plus A Cost Effective Strategies For Treating Multidrug-Resistant Tuberculosis?

A research paper published this week in the international open access journal PLoS Medicine evaluated the feasibility, effectiveness, cost, and cost-effectiveness of a DOTS-Plus pilot project established at Makati Medical Center in Manila, the Philippines, in 1999. The authors, led by Katherine Floyd of the World Health Organisation, studied 117 patients and showed that in this setting the average cost to the health system was US$3,355, and US$837 to the patients. [click link for full article]
(more...)


Exubera Effective In Diabetes Patients Who Have Respiratory Infections Or Are Exposed To Passive Cigarette Smoke, New Analyses Show

Adult patients with diabetes who took Exubera(R) (insulin human [rDNA origin]) inhalation powder were able to safely maintain good blood sugar control even if they developed a respiratory infection or were exposed to passive (second-hand) cigarette smoke. These analyses were presented today at the 42nd European Association for the Study of Diabetes. [click link for full article]
(more...)